Company / EPS (Diluted)
Maze Therapeutics, Inc. EPS (Diluted) History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.25
FY2025
5-year range
$1.25 / $1.25
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#30 of 204
Health Care
What the data says
Maze Therapeutics, Inc.'s eps (diluted) of $1.25 is higher than 85% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
1.25 in FY2025. Top quartile in the Health Care sector.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 204This company $1.25 Sector average -$0.89
▼
+241.0% above sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.25 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026